… to meglumine antimoniate in patients with localized cutaneous leishmaniasis from two
endemic areas of Brazil that were infected by two Leishmania species. Sixty-one were infected by …

… meglumine antimoniate (MA) in 24 not submitted to previous treatment patients with cutaneous
leishmaniasis (CL) and … Patients' age ranged from 3 to 90 years; fourteen were females. …

… Leishmaniasis (ACL) are associated with metastatic sequelae and treatment failure. In the
present study we found that in patients … antimonial derivatives in patients with ACL that did not …

… There is a clear need for new strategies of leishmaniasis treatment. This work … meglumine
antimoniate (Sb V ) in a phase II pilot clinical trial in localised cutaneous leishmaniasis patients…

… Nevertheless, it is clear that more large‐scale trials involving different populations of
leishmaniasis patients will be needed before specific treatment guidelines can be proposed. …

… of miltefosine to meglumine antimoniate in 63 patients with zoonotic cutaneous leishmaniasis
with … For randomization of patients into two groups, we used balanced block method. Then …

… meglumine antimoniate (Glucantime) for 80 patients with cutaneous leishmaniasis due to
Leishmania … This study was an open-label, randomized comparison of meglumine antimoniate (…

… patients with visceral leishmaniasis were treated with sodium stibogluconate (2 patients)
or meglumine antimoniate (3 patients… in the Leatment of visceral leishmaniasis, very little in…

… Four hundred patients with Old World CL, who had been referred to our Skin Disease and
Leishmania Research Center, were included in the study. All patients or their parents signed …

… comparative trial of amphotericin B and meglumine antimoniate to determine the efficacy
and safety of both drugs in the treatment of VL in patients with HIV infection. A secondary …